Teleflex Incorporated (NYSE:TFX) Receives $263.14 Consensus Price Target from Brokerages

Teleflex Incorporated (NYSE:TFXGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $264.57.

Several brokerages have recently weighed in on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Friday, May 3rd. Royal Bank of Canada raised their price target on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a report on Friday. Stephens upped their price target on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday. Truist Financial lifted their price objective on Teleflex from $235.00 to $240.00 and gave the company a “hold” rating in a research note on Tuesday, July 16th. Finally, Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the company from $205.00 to $245.00 in a report on Monday, July 1st.

Read Our Latest Stock Analysis on Teleflex

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. National Bank of Canada FI grew its holdings in Teleflex by 1,008.2% in the 2nd quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company’s stock worth $24,388,000 after acquiring an additional 104,935 shares during the last quarter. TD Asset Management Inc raised its position in shares of Teleflex by 12.0% in the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company’s stock worth $95,928,000 after acquiring an additional 48,832 shares in the last quarter. Cooke & Bieler LP raised its holdings in Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock worth $191,989,000 after purchasing an additional 172,335 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in Teleflex by 1.2% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock valued at $846,000 after acquiring an additional 46 shares during the period. Finally, Rhumbline Advisers lifted its holdings in shares of Teleflex by 1.3% during the second quarter. Rhumbline Advisers now owns 103,041 shares of the medical technology company’s stock valued at $21,673,000 after purchasing an additional 1,306 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Up 0.5 %

TFX stock opened at $237.13 on Friday. Teleflex has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The stock has a fifty day moving average of $214.14 and a 200-day moving average of $221.29. The company has a market capitalization of $11.17 billion, a price-to-earnings ratio of 38.06, a PEG ratio of 2.26 and a beta of 1.13. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.41 and a current ratio of 2.58.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. During the same period in the previous year, the business earned $3.41 EPS. Teleflex’s revenue was up .9% compared to the same quarter last year. As a group, equities research analysts predict that Teleflex will post 13.88 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Thursday, August 15th will be paid a $0.34 dividend. The ex-dividend date is Thursday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. Teleflex’s dividend payout ratio (DPR) is 21.83%.

Teleflex Company Profile

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.